Core Insights - Acadia Healthcare Company, Inc. (ACHC) reported adjusted second-quarter earnings of 83 cents per share, exceeding the Zacks Consensus Estimate by 16.9%, although the earnings declined 8.8% year over year [1][10] - Total revenues increased by 9.2% year over year to $869.2 million, surpassing the consensus mark by 4% [1][10] Financial Performance - Same-facility revenues reached $851.2 million, a 9.5% increase year over year, exceeding the estimate of $827.8 million [3] - Patient days increased by 1.8%, while admissions grew by 1.4% year over year [3] - Revenue per patient day rose by 7.5% year over year [3] - Total adjusted EBITDA increased by 7.6% year over year to $201.8 million, higher than the estimate of $178.4 million [4][10] Expense Analysis - Total expenses rose by 18.8% year over year to $819.2 million, exceeding the estimate of $760.2 million, driven by higher salaries, wages, benefits, and operating expenses [5] Cash and Debt Position - As of June 30, 2025, cash and cash equivalents were $131.4 million, up from $76.3 million at the end of 2024 [6] - Long-term debt increased to $2.2 billion from $1.9 billion as of December 31, 2024 [7] - Total assets grew to $6.3 billion from $6 billion at the end of 2024 [6] Share Repurchase Activity - The company repurchased shares worth $3.2 million in the quarter, totaling $50.4 million year-to-date, with $250 million remaining in the share repurchase fund [8] 2025 Guidance - Revenues are projected to be between $3.3 billion and $3.35 billion, with adjusted EBITDA estimated to be in the range of $675 million to $700 million [11] - Adjusted earnings per share (EPS) are expected to be between $2.45 and $2.65 [11] - Operating cash flows are forecasted to be between $460 million and $485 million [12]

Core Insights - Universal Health Services, Inc. (UHS) reported strong second-quarter 2025 results with adjusted earnings per share (EPS) of $5.35, exceeding estimates by 10.3% and reflecting a year-over-year increase of 24.1% [1][9] - Net revenues grew by 9.6% year over year to nearly $4.3 billion, surpassing the consensus mark by 1.5% [1][2] Financial Performance - Adjusted EBITDA, net of non-controlling interests (NCI), was $642.9 million, an improvement of nearly 11.1% year over year, exceeding the estimate of $602.8 million [3] - Total operating costs increased by 9% year over year to $3.8 billion, driven by higher salaries, wages, benefits, and other operating expenses [3][7] - Cash flows from operations were $549 million, a decline of 19.2% from the previous year [7] Segment Performance - Acute Care Hospital Services saw adjusted admissions rise by 2% on a same-facility basis, with net revenues increasing by 7.9% [4] - Behavioral Health Care Services experienced a 0.4% increase in adjusted admissions and an 8.9% rise in net revenues on a same-facility basis [5] Balance Sheet and Debt - As of June 30, 2025, UHS had cash and cash equivalents of $137.6 million, up from $126 million at the end of 2024 [6] - Total assets increased to $15 billion from $14.5 billion at the end of 2024, while long-term debt rose by 1.7% to $4.5 billion [6][7] - Total equity increased to $7.1 billion from $6.7 billion at the end of 2024 [7] Share Repurchase and Guidance - UHS repurchased shares worth $150.8 million in the second quarter, with a remaining repurchase capacity of approximately $492.9 million [10] - The company raised its full-year EPS guidance to $20-$21, reflecting improved revenue and EBITDA expectations [9][11]